Andrew T. Blair
No más puestos en curso
Perfil
Andrew T.
Blair held former positions as Vice President of Clinical Research at Genzyme Corp., Proteon Therapeutics, Inc., and Vice President of Medical Affairs at Affymax, Inc. He also worked as a Principal at the University of Texas Health Center.
Blair received his undergraduate degrees from Rush University and the University of Illinois.
Antiguos cargos conocidos de Andrew T. Blair.
| Empresas | Cargo | Fin |
|---|---|---|
| AFFYMAX, INC. | Director Técnico/Científico/I+D | - |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Director Técnico/Científico/I+D | - |
| University of Texas Health Center | Corporate Officer/Principal | - |
| PROTARA THERAPEUTICS, INC. | Director Técnico/Científico/I+D | - |
Formación de Andrew T. Blair.
| University of Illinois | Undergraduate Degree |
| Rush University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| AFFYMAX, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Proteon Therapeutics, Inc.
 Proteon Therapeutics, Inc. BiotechnologyHealth Technology Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Andrew T. Blair
